Intrinsic Value of S&P & Nasdaq Contact Us

NKGen Biotech, Inc. Common Stock NKGN OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
13/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — NKGN

NKGen Biotech, Inc. Common Stock (NKGN) has a market capitalization of $7.84M and trades at $0.06. The 52-week range is 0.001-0.765.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.54.

The stock has a beta of 0.81, operates in the Healthcare sector.

Trading Data
Current Price$0.06
52-Week Range0.001-0.765
Volume134
Avg Volume (30D)5.59K
Market Cap$7.84M
Beta (1Y)0.81
Company
IPO Date2023-10-02
Employees63
CEOPaul Y. Song
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS65488A1016
CUSIP65488A101
Income (Latest Year)
EBITDA$-26.97M
Operating Income$-26.97M
Net Income$-44.29M
EPS$-1.54
EPS Diluted$-1.54
Shares Outstanding$28.83M
Balance Sheet (Latest Year)
Total Assets$24K
Current Assets$24K
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message